BRIACELL THERAPEUTICS CORP. Increase Decrease In Cash And Cash Equivalents
BRIACELL THERAPEUTICS CORP. (BCTX) reported Increase Decrease In Cash And Cash Equivalents of -$12.74 million for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2022-06-13
CAD
| Period end | Increase Decrease In Cash And Cash Equivalents 0 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2020-07-31 | -112.82K CAD 40-F/A · filed 2021-11-16 | |
| 2019-08-01 | -758.07K CAD 40-F/A · filed 2021-11-16 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents 0 month | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|---|
| 2022-04-30 | -$3.45M derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | -$12.74M 6-K · filed 2022-06-13 | |||
| 2022-01-31 | -$9.29M 6-K · filed 2022-03-15 | ||||
| 2021-07-31 | $36.35M derived: 40-F/A 12 month − 6-K 9 month · filed 2021-11-16 | $57.22M derived: sum of 2 quarters · filed 2022-06-13 | $57.25M 40-F/A · filed 2021-11-16 | ||
| 2021-04-30 | $20.87M derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | $20.90M 6-K · filed 2022-06-13 | |||
| 2021-01-31 | $25.39K 6-K · filed 2022-03-15 | ||||
| 2020-07-31 | -$91.83K 40-F/A · filed 2021-11-16 | ||||
| 2019-08-01 | -$617.07K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |